R&D Pipeline


At Senores Pharmaceuticals, we are always working on innovating new and effective solutions that meet the complex and increasing demands of the patients and the industry. Our in-house R&D team dedicates their expertise and experience to develop, test, and perfect new products according to the new demands of the market.

USA Market


Products R&D Scale Up ANDA Preparation ANDA Filed ANDA Approved
Amphetamine Sulfate Tablets USP, 5 mg and 10 mg

100%

Hydroxychloroquine Sulfate Tablets USP, 200 mg

100%

Ketoconazole Tablets USP,
200 mg

100%

Chlorzoxazone Tablets USP,
250 mg

100%

Butalbital, Acetaminophen and Caffeine Capsules USP, 50mg; 300mg; 40mg and 50mg; 325mg; 40mg

100%

Mexiletine Hydrochloride Capsules USP, 150 mg, 200 mg and 250 mg

100%

Butalbital and Acetaminophen Tablets USP, 50 mg; 300 mg, 25 mg; 325 mg and 50 mg; 325 mg

100%

Ketorolac Tromethamine Tablets USP, 10 mg

100%

Product 9

60%

Product 10

60%

Product 11

60%

Product 12

60%

Product 13

40%

Product 14

40%

Product 15

40%

Product 16

40%

Product 17

40%

Product 18

40%

Product 19

10%

Product 20

10%

Product 21

410%

Product 22

40%

Product 23

10%

Product 24

10%

Product 25

10%

Product 26

10%

Product 27

10%

Product 28

10%

Product 29

10%

Specialty Products


Products R&D Scale Up ANDA Preparation ANDA Filed ANDA Approved
Product 1

100%

Product 2

60%

Product 3

40%

Product 4

40%

Canada Market


Products R&D Scale Up ANDA Preparation ANDA Filed ANDA Approved
Product 1

60%

Product 2

60%